Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析

◆英語タイトル:Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66572FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Avadel Pharmaceuticals Plc (AVDL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells products in the US and Ireland. The company operates in St. Louis, Missouri and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Mar 09,2021: Avadel Pharmaceuticals provides corporate update and reports fourth quarter and full year 2020 financial results
Feb 23,2021: Avadel Pharmaceuticals to Provide a Company Update and Report Fourth Quarter and Full Year 2020 Financial Results, on March 9th
Feb 17,2021: Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
Feb 10,2021: Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09,2020: Avadel Pharmaceuticals reports third quarter 2020 financial results and provides update on FT218 development program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Avadel Pharmaceuticals Plc – Key Facts
Avadel Pharmaceuticals Plc – Key Employees
Avadel Pharmaceuticals Plc – Key Employee Biographies
Avadel Pharmaceuticals Plc – Major Products and Services
Avadel Pharmaceuticals Plc – History
Avadel Pharmaceuticals Plc – Company Statement
Avadel Pharmaceuticals Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avadel Pharmaceuticals Plc – Business Description
Product Category: Akovaz
Overview
Performance
Product Category: Bloxiverz
Overview
Performance
Product Category: Other
Performance
Product Category: Vazculep
Overview
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: United States
Performance
Avadel Pharmaceuticals Plc – Corporate Strategy
Avadel Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Avadel Pharmaceuticals Plc – Strengths
Avadel Pharmaceuticals Plc – Weaknesses
Avadel Pharmaceuticals Plc – Opportunities
Avadel Pharmaceuticals Plc – Threats
Avadel Pharmaceuticals Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Avadel Pharmaceuticals Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 09, 2021: Avadel Pharmaceuticals provides corporate update and reports fourth quarter and full year 2020 financial results
Feb 23, 2021: Avadel Pharmaceuticals to Provide a Company Update and Report Fourth Quarter and Full Year 2020 Financial Results, on March 9th
Feb 17, 2021: Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
Feb 10, 2021: Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09, 2020: Avadel Pharmaceuticals reports third quarter 2020 financial results and provides update on FT218 development program
Aug 10, 2020: Avadel Pharmaceuticals reports second quarter 2020 financial results and recent business update
May 11, 2020: Avadel Pharmaceuticals reports first quarter 2020 financial results
Mar 12, 2020: Avadel Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 21, 2020: Avadel Pharmaceuticals announces $65 million Private Placement with leading biotech investment funds
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Avadel Pharmaceuticals Plc, Key Facts
Avadel Pharmaceuticals Plc, Key Employees
Avadel Pharmaceuticals Plc, Key Employee Biographies
Avadel Pharmaceuticals Plc, Major Products and Services
Avadel Pharmaceuticals Plc, History
Avadel Pharmaceuticals Plc, Subsidiaries
Avadel Pharmaceuticals Plc, Key Competitors
Avadel Pharmaceuticals Plc, Ratios based on current share price
Avadel Pharmaceuticals Plc, Annual Ratios
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...1)
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...2)
Avadel Pharmaceuticals Plc, Interim Ratios
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Avadel Pharmaceuticals Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinclair Broadcast Group Inc (SBGI):企業の財務・戦略的SWOT分析
    Summary Sinclair Broadcast Group Inc (Sinclair) is a television broadcasting service provider that owns and operates television programs. The company's service portfolio includes content creation, distribution platforms, advertising platform and technical solutions. It offers content across various …
  • Dean Foods Co:企業のM&A・事業提携・投資動向
    Dean Foods Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dean Foods Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Great Southern Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Boardwalk Pipeline Partners LP:企業のM&A・事業提携・投資動向
    Boardwalk Pipeline Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boardwalk Pipeline Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Trican Well Service Ltd (TCW):石油・ガス:M&Aディール及び事業提携情報
    Summary Trican Well Service Ltd (Trican) is an oilfield services company, which provides specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, coiled tubin …
  • Cairn India Ltd (CAIRN)-石油・ガス分野:企業M&A・提携分析
    Summary Cairn India Limited (Cairn India) is an independent oil and gas company. It explores for, develops, and produces oil and natural gas. The company has varying working interests in India, Sri Lanka and South Africa. Its blocks are located in the basins of Barmer, Krishna- Godavari, the Palar-P …
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • Enzon Pharmaceuticals Inc (ENZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Enzon Pharmaceuticals Inc (Enzon), formerly Enzon, Inc., is a pharmaceutical company that receives royalty revenues from existing licensing arrangements. The company has licensing arrangements with other companies related to sales of their four marketed drug products, namely, PegIntron, Syla …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • Kobayashi Pharmaceutical Co Ltd (4967):製薬・医療:M&Aディール及び事業提携情報
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Jinchuan Group International Resources Co. Ltd:企業の戦略・SWOT・財務情報
    Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • QPS Holdings LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Holdings LLC (QPS) is a contract research organization that offers bioanalytical contract services. The organization’s services include neuropharmacology, toxicology, DMPK, bioanalysis, translational medicine, clinical development, clinical research, and dermal and transdermal research s …
  • Wilmar International Limited:企業の戦略・SWOT・財務分析
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Skechers USA Inc (SKX):企業の財務・戦略的SWOT分析
    Skechers USA Inc (SKX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mitsui O.S.K. Lines Ltd (9104):企業の財務・戦略的SWOT分析
    Mitsui O.S.K. Lines Ltd (9104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Centric Health Corporation:企業のM&A・事業提携・投資動向
    Centric Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Centric Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆